1-5 of 5
Authors: Jacob Henderson
Journal Article
IMMU-14. IMMUNE CHECKPOINT INHIBITOR THERAPY FOR TREATMENT OF SYNCHRONOUS CANCERS IN PAEDIATRIC PATIENTS WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY Open Access
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii362, https://doi.org/10.1093/neuonc/noaa222.370
Published: 04 December 2020
Journal Article
MEDU-47. A NOVEL TGF-BETA/MYC-DRIVEN MEDULLOBLASTOMA MODEL TO STUDY IMMUNE-TUMOR INTERACTIONS Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii113, https://doi.org/10.1093/neuonc/noz036.205
Published: 23 April 2019
Journal Article
IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii98, https://doi.org/10.1093/neuonc/noz036.143
Published: 23 April 2019
Journal Article
PDTM-36. FUNCTIONAL GENOMIC ANALYSIS OF MYC-AMPLIFIED MEDULLOBLASTOMA NOMINATES THE TGFB PATHWAY AS A CLINICALLY VIABLE TARGET Free
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi197, https://doi.org/10.1093/neuonc/nox168.799
Published: 06 November 2017
Journal Article
MB-20EVALUATING THE ONCOGENIC POTENTIAL OF TSC1/2 MUTATIONS AND EFFICACY OF MTOR INHIBITORS IN HIGH RISK PEDIATRIC MEDULLOBLASTOMA Get access
Neuro-Oncology, Volume 17, Issue suppl_3, June 2015, Page iii24, https://doi.org/10.1093/neuonc/nov061.96
Published: 21 April 2015
